Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical ...
The new sequence – named T2T-CHM13 – was made possible through combining the advantages of new, competing long-read technologies from Pacific Biosciences (CA, USA) and Oxford Nanopore (UK), which ...